Our sterile complex in Bangalore, India can produce products in a spectrum of therapeutic areas including beta-lactams and cephalosporins in multiple dosage forms.

The facility for non ceph non beta lactam steriles is approved by US FDA, MHRA, TGA, MCC and ANVISA. The facility for beta lactams is approved by MHRA, TGA, MCC and ANVISA.

We have four manufacturing facilities in India and Poland with new green-field sites for penems coming up in Brazil. Our new green-field site coming up in India will include FDV, Oncology and a Hormonal Block. We have over 40 products licensed in regulated markets and over 20 ANDA filings to add to a strong pipeline of over 80 products in development.